Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04113018
Title Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
*Shaded cells indicate that there was no data available from for the field